57-Cobalt-bleomycin as a tumor scanning agent in primary hepatocellular cancer
Authors:
- 1 January 1976
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 1 (4) , 247-250
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.1975
- Chemical and biologic properties of isolated radiolabeled bleomycin preparations.1975
- Gallium-67-citrate scanning in primary cancer of the liver: diagnostic value in the presence of cirrhosis and relation to alpha-fetoprotein.1975
- Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate.1975
- Clinical Evaluation of Tumor Scanning with57Co-BleomycinRadiology, 1974
- Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.1974
- Comparison between 57Co-bleomycin, 99mTc-bleomycin and 111In-bleomycin as the Tumor Scanning AgentsRADIOISOTOPES, 1974
- Uptake of 57Co-Bleomycin by Liver TumorRADIOISOTOPES, 1973
- ON THE MECHANISM OF ACTION OF BLEOMYCINThe Journal of Antibiotics, 1970
- Cancer Incidence in the Bantu and “Cape Colored” Races of South Africa: Report of a Cancer Survey in the Transvaal (1953–55)2JNCI: Journal of the National Cancer Institute, 1960